Search
Search titles only
By:
Search titles only
By:
Log in
Register
Search
Search titles only
By:
Search titles only
By:
Menu
Install the app
Install
Forums
New posts
All threads
Latest threads
New posts
Trending threads
Trending
Search forums
What's new
New posts
New ads
New profile posts
Latest activity
Free Ads
Latest reviews
Search ads
Members
Current visitors
New profile posts
Search profile posts
Contact us
Latest ads
ඔයාගෙ Assignment හෝ Thesis එක හරියට හදාගමු
ErMurazor
Updated:
Saturday at 10:52 PM
Ad icon
BlackWall V2ray servers
hu KANNA
Updated:
Wednesday at 4:58 AM
Peppa Pig Family Plush Toy Set – 5 Characters
anil1961
Updated:
Sep 19, 2026
Ad icon
Express VPN PC - 1 Year Rs. 600.00
Sanathbh
Updated:
Sep 19, 2026
Ad icon
Capcut Pro 7 Days Team Plan - Rs. 3️⃣0️⃣0️⃣
Sanathbh
Updated:
Sep 19, 2026
Electronics
Vehicles
Property
Search
Reply to thread
Forums
General
ElaKiri Talk!
Nipah virus outbreak -India(ආයෙත්)
Get the App
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Message
<blockquote data-quote="imhotep" data-source="post: 31208989" data-attributes="member: 562115"><p>Nipah raises it's head in India from time to time. Mostly in Kerala. Origin of Nipah was Malaysia in 1998. It's a member of the family <em>Paramyxoviridae</em>, genus <em>Henipavirus</em>. Mortality between 40% to 70%.</p><p>The viral genome consists of a <strong>non-segmented negative sense single-stranded RNA of approximately 18.2 kb long</strong> which encodes six structural proteins.</p><p></p><p>Recently (last December) it was announced that a<strong> Phase-I study of a vaccine was very promising</strong> and provides hope for further testing on a Phase -II trial.</p><p>Due to the structural and sequence similarities between the NiV and Hendra virus (HeV) attachment G glycoproteins, and the extensive extant evidence of the ability of a recombinant soluble glycoprotein G (HeV-sG) to provide heterologous cross-protective immunity when used as vaccine HeV-sG-V.</p><p></p><p>The immune response to HeV-sG-V was dose-dependent; a single administration was not sufficiently immunogenic, whereas two administrations were immunogenic, with the highest response rates observed among vaccinees that received two administrations of the 100 μg HeV-sG-V 28 days apart.</p></blockquote><p></p>
[QUOTE="imhotep, post: 31208989, member: 562115"] Nipah raises it's head in India from time to time. Mostly in Kerala. Origin of Nipah was Malaysia in 1998. It's a member of the family [I]Paramyxoviridae[/I], genus [I]Henipavirus[/I]. Mortality between 40% to 70%. The viral genome consists of a [B]non-segmented negative sense single-stranded RNA of approximately 18.2 kb long[/B] which encodes six structural proteins. Recently (last December) it was announced that a[B] Phase-I study of a vaccine was very promising[/B] and provides hope for further testing on a Phase -II trial. Due to the structural and sequence similarities between the NiV and Hendra virus (HeV) attachment G glycoproteins, and the extensive extant evidence of the ability of a recombinant soluble glycoprotein G (HeV-sG) to provide heterologous cross-protective immunity when used as vaccine HeV-sG-V. The immune response to HeV-sG-V was dose-dependent; a single administration was not sufficiently immunogenic, whereas two administrations were immunogenic, with the highest response rates observed among vaccinees that received two administrations of the 100 μg HeV-sG-V 28 days apart. [/QUOTE]
Insert quotes…
Verification
Winadiyakata thappara keeyak tibeda?
Post reply
Top
Bottom